In recent years, significant scientific breakthroughs have opened the door to harnessing the immune system to fight cancer. One potential group of targets, known as G protein coupled receptors (GPCRs), have proven challenging due to their membrane localization and the existence of several close analogues, which often leads to ineffective or even non-specific mode of […]
Read More